GSTA4 and central nervous system cancer: Previous studies have reported that decreased expression of GSTA4 is associated with positive outcomes in glioma models (Cheng et al., 2022), whereas increased expression of GSTA4 promotes the malignant progression of liver cancer (Liu et al., 2017).